Aspen Pharmacare
VerifiedA global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$8.7b (Public information from Jun 2024)
Share price
ZAR231.03 APN.JO
Durban KwaZulu-Natal (HQ)
| ZAR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (2 %) | 2 % | 5 % | 9 % | 14 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 28 % | 26 % | 28 % | 26 % | 25 % | 28 % | 28 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 12 % | 13 % | 17 % | 13 % | 14 % | 17 % | 18 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
* | $30.0m | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about Aspen Pharmacare
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.